基本信息
views: 16
Career Trajectory
Bio
Cecilie Johannessen Landmark currently works at the Program for Pharmacy, Oslo Metropolitan University and The National Center for Epilepsy and Dept of Pharmacology, Oslo University Hospital. Cecilie does research in Clinical Pharmacology of antiepileptic drugs, patient and population aspects. She is Professor of pharmacology, research group leader, medical advisor, and head of the pharmacology team at the hospital
Research Interests
Papers共 147 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Epilepsia openno. 2 (2024): 475-485
EPILEPSIA OPENno. 2 (2024): 475-485
THERAPEUTIC DRUG MONITORINGno. 5 (2024): 664-671
Katrine Heger,Kari Kjeldstadli, Nelly Ring,Kari Modalsli Aaberg, Signe Flood Kjeldsen,Margrete Larsen Burns,Svein I. Johannessen,Cecilie Johannessen Landmark
THERAPEUTIC DRUG MONITORINGno. 2 (2024): 237-245
Kjersti Kirkeby,Ine Cockerell,Jakob Christensen,Christina Engel Hoei-Hansen, Lotte Holst, Mikkel G. Fredriksen,Caroline Lund,Cecilie Johannessen Landmark
MEDICINEno. 32 (2024)
Cathrine Elisabeth Gjerulfsen, Madeleine Oudin,Francesca Furia, Sopio Gverdtsiteli,Cecilie Johannessen Landmark,Marina Trivisano, Angel Aledo-Serrano, Ricardo Morcos,Roberto Previtali, Pierangelo Veggiotti,Emilia Ricci,Guido Rubboli,Elena Gardella, Rikke Moller
crossref(2024)
ORPHANET JOURNAL OF RARE DISEASESno. 1 (2023)
J. Saetre, M. Wolden,A. Gottas, T. Angell-Petersen McQuade, S. Flood Kjeldsen, A. Vatevik,E. Saetre,T. Svendsen,M. L. Burns,S. I. Johannessen,E. L. Oiestad,C. Johannessen Landmark
EPILEPSIA (2023): 314-315
Cited0Views0Bibtex
0
0
Load More
Author Statistics
#Papers: 147
#Citation: 3222
H-Index: 29
G-Index: 55
Sociability: 6
Diversity: 0
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn